Breaking News

Covance Launches Lab Solution within FSPx Offering

Program comprises a clinical analytics service and clinical operations capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

LabCorp’s Covance Drug Development business has launched a laboratory solution within its functional service provider (FSPx) offering. The acquisition of Chiltern in 2017 substantially expanded the company’s FSP offerings and this newly enlarged service, renamed FSPx, comprises a clinical analytics service and clinical operations capabilities.   Clinical analytics now includes Laboratory FSPx, which aims to deliver customized global data solutions that enable clients to better manage laborator...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters